Medindia

X

Tamoxifen may Help Reduce Breast Cancer Risk Among High-Risk Patients

by Kathy Jones on  April 16, 2013 at 10:08 PM Cancer News   - G J E 4
A new study published in the Annals of Internal Medicine suggests that women who have a high risk of developing breast cancer can benefit by using the drugs tamoxifen and raloxifene (Evista).
 Tamoxifen may Help Reduce Breast Cancer Risk Among High-Risk Patients
Tamoxifen may Help Reduce Breast Cancer Risk Among High-Risk Patients
Advertisement

Researchers led by Dr Heidi Nelson from Oregon Health and Science University in Portland analyzed studies which compared the instances of breast cancer among women placebo and  tamoxifen.

Advertisement
The researchers found that around 23.5 women per 1,000 women developed breast cancer among those who took placebo over a period of five years compared to 16.5 percent 1,000 women who took tamoxifen during the same period.

"Tamoxifen is more effective at reducing breast cancer risk, but it has more side effects. Some women have side effects that are not life-threatening but they are uncomfortable and not minor, and cause them to stop medications, such as vaginal discharge, dryness, itching, leg cramps", Nelson said.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All